More on AMAR
Financials
News
Click line-items for a historical chart and %
| Net cash used in operating activities | -426.99K |
| Patent expenditures | -54.48K |
| Net cash used in investing activities | -102.17K |
| Proceeds from issuance of convertible note payable | |
| Proceeds from notes payable – related party | 262.5K |
| Proceeds from exercise of options | |
| Proceeds from sale of convertible preferred stock | |
| Proceeds from sale of common stock | |
| Net cash provided by financing activities | 684.38K |
| Net change in cash | 155.22K |
| Cash and cash equivalents at beginning of period | 21.14K |
| Cash and cash equivalents at end of period | 176.36K |
| Cash paid for interest | 1.07K |
| Discount on convertible notes payable | |
Entities mentioned with AMAR
- 13D | View Related Stories »
- NT 10-Q | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- BofA/Merrill Lynch | View Related Stories »
- ARK | View Related Stories »
- Bankruptcy | View Related Stories »
- Show More...
